Based on the Astec LifeSciences Limited stock forecast from 0 analysts, the average analyst target price for Astec LifeSciences Limited is not available over the next 12 months. Astec LifeSciences Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Astec LifeSciences Limited is Bearish, which is based on 2 positive signals and 10 negative signals. At the last closing, Astec LifeSciences Limited’s stock price was INR 983.75. Astec LifeSciences Limited’s stock price has changed by -9.34% over the past week, -7.92% over the past month and -11.65% over the last year.
No recent analyst target price found for Astec LifeSciences Limited
No recent average analyst rating found for Astec LifeSciences Limited
Company Overview Astec LifeSciences Limited
Astec LifeSciences Limited, together with its subsidiaries, engages in the manufacture and sale of agrochemical active ingredients and pharmaceutical intermediates in India. It offers triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservative. The company also provides herbicides, insecticides, and specialty chemical products. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited. Read Less
Astec LifeSciences Limited, together with its subsidiaries, engages in the manufacture and sale of agrochemical active ingredients and pharmaceutical intermediates in India. It offers triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mi...Read More
Frequently Asked Questions About Astec LifeSciences Limited (ASTEC:NSE) Stock
Stock Target Advisor's fundamental analysis for Astec LifeSciences Limited's stock is Bearish.
Unfortunately we do not have enough data on ASTEC:NSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ASTEC:NSE's stock to indicate what its average analyst target is.
ASTEC:NSE stock's Price/Earning ratio is 411.55.
Our analysis grades ASTEC:NSE stock's Price / Earning ratio at F. This means that ASTEC:NSE stock's Price/Earning ratio is above 93% of the stocks in the Agricultural Inputs sector in the NSE exchange.
Based on this ASTEC:NSE may be a overvalued for its sector.
The last closing price of ASTEC:NSE's stock was INR 983.75.
The most recent market capitalization for ASTEC:NSE is INR 20.40B.
Unfortunately we do not have enough analyst data on ASTEC:NSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Astec LifeSciences Limited's stock.
As per our most recent records Astec LifeSciences Limited has 606 Employees.
Astec LifeSciences Limited's registered address is Godrej One, Mumbai, India, 400079.
You can get more information about it from Astec LifeSciences Limited's website at https://www.godrejastec.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Astec LifeSciences Limited (ASTEC:NSE) Stock
Stock Target Advisor's fundamental analysis for Astec LifeSciences Limited's stock is Bearish.
Unfortunately we do not have enough data on ASTEC:NSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ASTEC:NSE's stock to indicate what its average analyst target is.
ASTEC:NSE stock's Price/Earning ratio is 411.55.
Our analysis grades ASTEC:NSE stock's Price / Earning ratio at F. This means that ASTEC:NSE stock's Price/Earning ratio is above 93% of the stocks in the Agricultural Inputs sector in the NSE exchange.
Based on this ASTEC:NSE may be a overvalued for its sector.
The last closing price of ASTEC:NSE's stock was INR 983.75.
The most recent market capitalization for ASTEC:NSE is INR 20.40B.
Unfortunately we do not have enough analyst data on ASTEC:NSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Astec LifeSciences Limited's stock.
As per our most recent records Astec LifeSciences Limited has 606 Employees.
Astec LifeSciences Limited's registered address is Godrej One, Mumbai, India, 400079.
You can get more information about it from Astec LifeSciences Limited's website at https://www.godrejastec.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ASTEC:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
